Rights and permissions
About this article
Cite this article
Nonbiologic DMARD combination therapies cost effective in early RA. Pharmacoecon. Outcomes News 631, 7 (2011). https://doi.org/10.2165/00151234-201106310-00015
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-201106310-00015